Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: An analysis of six cases

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 372-380

  Cho, K H ^a   Lee, S H ^a   Kim, C W ^a   Jeon, Y K ^a   Kwon, I H ^a   Cho, Y J ^a   Lee, S K ^b   Suh, D H ^a   Chung, J H ^a   Yoon, T Y ^c   Lee, S J ^d  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

Author keywords

Epstein Barr virus; Hydroa vacciniforme; Photoprovocation

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ADULT; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HYDROA VACCINIFORME; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; RADIATION EXPOSURE; RASH; REMISSION; REVIEW; SKIN BIOPSY; T LYMPHOCYTE RECEPTOR GENE; ULTRAVIOLET RADIATION; VIRUS INFECTION;

ADOLESCENT; ADULT; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FACIAL DERMATOSES; FEMALE; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; HYDROA VACCINIFORME; IN SITU HYBRIDIZATION; LEUKOCYTES, MONONUCLEAR; MALE; NECROSIS; POLYMERASE CHAIN REACTION; PREDNISOLONE; RECURRENCE; SEVERITY OF ILLNESS INDEX; ULTRAVIOLET RAYS;

EID: 4544235769     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06038.x     Document Type: Review

References (20)

1. Oono T, Arata J, Masuda T et al. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 1986; 122: 1306-9.
2. Okada N, Tei H, Yamamura T et al. Recurrent mucocutaneous lymphocytic infiltration possibly associated with Epstein-Barr virus infection. Dermatologica 1991; 183: 139-42.
3. Ruiz-Maldonado R, Millan-Parilla F, Orozco-Covarrubias ML et al. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 1995; 32: 37-44.
4. Tabata N, Aiba S, Ichinohazama R et al. Hydroa vacciniforme-like lymphomatoid papulosis in a Japanese child: a new subset. J Am Acad Dermatol 1995; 32: 378-81.
5. Cho KH, Kim CW, Lee DY et al. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol 1996; 134: 791-6.
6. Asada H, Okada N, Tei H et al. Epstein-Barr virus associated large granular lymphocytic leukemia with cutaneous infiltration. J Am Acad Dermatol 1994; 31: 251-5.
7. Cho K-H, Kim C-W, Kwon O-S et al. Epstein-Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia. Br J Dermatol 1997; 137: 426-30.
8. Cho K-H, Kim C-W, Heo D-S et al. Epstein-Barr virus associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol 2002; 26: 242-7.
9. Magana M, Sangueza P, Gil-Beristain J et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998; 38: 574-9.
10. Iwatsuki K, Ohtsuka M, Akiba H, Kaneko F. Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy. J Am Acad Dermatol 1999; 40: 283-4.
11. Iwatsuki K, Xu Z, Takata M et al. The association of Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999; 140: 715-21.
12. Bickers DR, De Mar LK, De Leo V et al. Hydroa vacciniforme. Arch Dermatol 1978; 114: 1193-6.
13. Wong S-N, Tan SH, Khoo SW. Late-onset hydroa vacciniforme: two case reports. Br J Dermatol 2001; 144: 874-7.
14. Sonnex TS, Hawk JLM. Hydroa vacciniforme: a review of ten cases. Br J Dermatol 1988; 118: 101-8.
15. Iwatsuki K, Ohtsuka M, Harada H et al. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997; 133: 1081-6.
16. Ohtsuka T, Okita H, Otuka S et al. Hydroa vacciniforme with latent Epstein-Barr virus infection. Br J Dermatol 2001; 145: 509-10.
17. Tokura Y, Ishihara S, Ohshima K et al. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol 1998; 138: 905-6.
18. Tokura Y, Tamura Y, Takigawa M et al. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 1990; 126: 362-8.
19. Tokura Y, Ishihara S, Tagawa S et al. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001; 45: 569-78.
20. Chen H-H, Hsiao C-H, Chiu H-C. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol 2002; 147: 587-91.